Home
Resource
The effect of tea polyphenols on chronic disease: obesity, the metabolic syndrome, and colon cancer
PDF
PDF format is widely accepted and good for printing.
Plug-in required
PDF-1(1.07 MB)
Citation & Export
View Usage Statistics
Staff View

Citation & Export
Hide

Simple citation

Bose, Mousumi. The effect of tea polyphenols on chronic disease: obesity, the metabolic syndrome, and colon cancer. Retrieved from https://doi.org/doi:10.7282/T3T72HWK

Export

Click here for information about Citation Management Tools at Rutgers.

Statistics
Hide

Description

Uniform TitleThe effect of tea polyphenols on chronic disease: obesity, the metabolic syndrome, and colon cancer
NameBose, Mousumi (author); yang, chung (chair); Reddy, Bandaru (internal member); Shapses, Sue (internal member); Storch, Judith (internal member); Suh, Nanjoo (outside member); Rutgers University; Graduate School - New Brunswick
Date Created2007
Other Date2007 (degree)
SubjectNutritional Sciences, Plant polyphenols, Tea, Cancer, Obesity, Metabolic syndrome
Extentxvi, 129 pages
DescriptionThe prevalence of obesity and the metabolic syndrome has more than doubled in the last 30 years. Colon cancer is the second leading cause of cancer-related death in the United States. Many studies show beneficial effects of certain dietary constituents, including green tea, in the prevention of these diseases. In the first set of experiments, I determined the effect of (-)-epigallocatechin-3-gallate (EGCG) on weight gain and related factors in a high-fat diet-induced mouse model for obesity and the metabolic syndrome. I found that l6-week treatment of 0.32% EGCG in the diet (w/w) significantly reduced body weight gain ([greater than sign]50%) and body fat percentage (by 10%) in comparison to control mice. Visceral fat weight was significantly decreased by EGCG treatment. Biochemical measurements revealed that EGCG treatment significantly attenuated insulin resistance and plasma cholesterol. Liver pathologies were significantly lessened by EGCG, as indicated by decreased liver weight, triglyceride content, and transaminase release into plasma. Plasma monocyte chemoattractant protein (MCP-1) levels were also decreased by EGCG, suggesting reduction of inflammation by EGCG.
In the next set of experiments, I determined the effect of a combination of EGCG (0.16% in the drinking fluid) and fish oil in the diet (12% w/w), on intestinal tumorigenesis in ApcMin/+ mice. Combination treatment reduced tumor number by 53% compared to controls; at the doses used, neither agent alone had a significant effect. β-catenin nuclear positivity in intestinal adenomas from the combination group was lower than control mice, indicating modulation of Wnt signaling. Fish oil and the combination significantly reduced prostaglandin E2 levels in adenomas compared to controls, suggesting modulation of aberrant arachidonic acid metabolism. Akt phosphorylation in adenomas was significantly reduced in all treatment groups, which may have contributed to the observed increase in apoptosis. The results from these two studies indicate that long-term treatment with EGCG decreases risk for obesity and conditions associated with the metabolic syndrome, and that a combination of EGCG and fish oil can inhibit intestinal tumorigenesis in ApcMin/+ mice. These effects may be mediated through multiple mechanisms and should be addressed in future studies in the prevention of chronic disease.
NotePh.D.
NoteIncludes bibliographical references (p. 104-127).
Genretheses, ETD doctoral
Persistent URLhttps://doi.org/doi:10.7282/T3T72HWK
LanguageEnglish
CollectionGraduate School - New Brunswick Electronic Theses and Dissertations
Organization NameRutgers, The State University of New Jersey
RightsThe author owns the copyright to this work.
Version 8.5.5
Rutgers University Libraries - Copyright ©2024